167 related articles for article (PubMed ID: 23302449)
1. A case of recurrent psychosis during sickle cell disease crisis treated successfully with ziprasidone.
Spiegel DR; Messerschmidt C; Morewitz J; Akintola M
Clin Schizophr Relat Psychoses; 2013 Jan; 6(4):197-201. PubMed ID: 23302449
[TBL] [Abstract][Full Text] [Related]
2. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
Zhao T; Park TW; Yang JC; Huang GB; Kim MG; Lee KH; Chung YC
Int Clin Psychopharmacol; 2012 Jul; 27(4):184-90. PubMed ID: 22426471
[TBL] [Abstract][Full Text] [Related]
4. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
Oechsner M; Korchounov A
Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic treatment of psychosis associated with multiple sclerosis.
Davids E; Hartwig U; Gastpar M
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):743-4. PubMed ID: 15276702
[TBL] [Abstract][Full Text] [Related]
6. Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission.
Ketter TA; Agid O; Kapur S; Loebel A; Siu CO; Romano SJ
J Psychiatr Res; 2010 Jan; 44(1):8-14. PubMed ID: 19699488
[TBL] [Abstract][Full Text] [Related]
7. [Acute painful crisis in a female Nigerian patient with sickle cell disease].
Nin S; Seki M; Maie K; Kuroda A; Miyamoto K; Ogawa S; Ito Y; Kurita N; Yokoyama Y; Sakata Yanagimoto M; Obara N; Hasegawa Y; Ogino Y; Ito T; Chiba S
Rinsho Ketsueki; 2015 Jan; 56(1):30-4. PubMed ID: 25745965
[TBL] [Abstract][Full Text] [Related]
8. Intravenous support for the patient in sickle cell crisis.
Odesina V
J Intraven Nurs; 2001; 24(1):32-7. PubMed ID: 11836842
[TBL] [Abstract][Full Text] [Related]
9. Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial.
Pintor L; Valldeoriola F; Baillés E; Martí MJ; Muñiz A; Tolosa E
Clin Neuropharmacol; 2012; 35(2):61-6. PubMed ID: 22388466
[TBL] [Abstract][Full Text] [Related]
10. Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature.
Uprety D; Baber A; Foy M
Ann Hematol; 2014 May; 93(5):769-71. PubMed ID: 24232306
[TBL] [Abstract][Full Text] [Related]
11. Pediatric uptake of a newly available antipsychotic medication.
Penfold RB; Kelleher KJ; Wang W; Strange B; Pajer K
Pediatrics; 2010 Mar; 125(3):475-82. PubMed ID: 20142282
[TBL] [Abstract][Full Text] [Related]
12. Approach to the vaso-occlusive crisis in adults with sickle cell disease.
Yale SH; Nagib N; Guthrie T
Am Fam Physician; 2000 Mar; 61(5):1349-56, 1363-4. PubMed ID: 10735342
[TBL] [Abstract][Full Text] [Related]
13. Ziprasidone induced symptomatic bradycardia: a case report.
Menon V; Kattimani S; Ayyanar S
Aust N Z J Psychiatry; 2011 Sep; 45(9):789. PubMed ID: 21668298
[No Abstract] [Full Text] [Related]
14. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
15. Rapid Fire: Sickle Cell Disease.
Porter M
Emerg Med Clin North Am; 2018 Aug; 36(3):567-576. PubMed ID: 30037443
[TBL] [Abstract][Full Text] [Related]
16. Ziprasidone in the treatment of Parkinson's disease psychosis.
Shiah IS; Lin CL; Mao WC; Luu SU
Eur Psychiatry; 2006 Dec; 21(8):578-9. PubMed ID: 16139485
[No Abstract] [Full Text] [Related]
17. [Quetiapine and ziprasidone in the treatment of the psychotic disorders in Parkinson's disease].
López del Val LJ; Santos S
Rev Neurol; 2004 Oct 1-15; 39(7):661-7. PubMed ID: 15490355
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for the management of the acute painful crisis in sickle cell disease.
Rees DC; Olujohungbe AD; Parker NE; Stephens AD; Telfer P; Wright J;
Br J Haematol; 2003 Mar; 120(5):744-52. PubMed ID: 12614204
[No Abstract] [Full Text] [Related]
19. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
Borovicka MC; Bond LC; Gaughan KM
Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
[TBL] [Abstract][Full Text] [Related]
20. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
